HPD Human

4-Hydroxyphenylpyruvate Dioxygenase Human Recombinant
Shipped with Ice Packs
In Stock

Description

HPD produced in E.Coli is a single, non-glycosylated polypeptide chain containing 413 amino acids (1-393a.a.) and having a molecular mass of 47kDa.
HPD is fused to a 20 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.

Product Specs

Introduction
4-Hydroxyphenylpyruvate Dioxygenase Isoform-1, an Fe-containing enzyme, catalyzes the conversion of 4-hydroxyphenylpyruvate to homogentisate, the second step in tyrosine catabolism. This homodimeric enzyme utilizes zinc as a cofactor to catalyze the third step in the conversion of L-phenylalanine to fumarate and acetoacetic acid. Genetic defects in HPD can lead to tyrosinemia type 3 and hawkinsinuria, two inborn metabolic disorders characterized by various symptoms such as mental retardation, seizures, and hair and urine abnormalities.
Description
Produced in E. coli, our HPD is a single, non-glycosylated polypeptide chain consisting of 413 amino acids (1-393a.a.) with a molecular weight of 47kDa. It features a 20 amino acid His-tag at the N-terminus and is purified using proprietary chromatographic techniques.
Physical Appearance
Clear, sterile filtered solution.
Formulation
The HPD protein solution (1mg/ml) is supplied in 20mM Tris-HCl buffer (pH 8.0) containing 1mM DTT, 50mM NaCl, and 20% glycerol.
Stability
For short-term storage (2-4 weeks), the product can be stored at 4°C. For extended storage, freezing at -20°C is recommended. Adding a carrier protein (0.1% HSA or BSA) is advisable for long-term storage. Avoid repeated freeze-thaw cycles.
Purity
Purity exceeds 90% as determined by SDS-PAGE analysis.
Synonyms
4HPPD, GLOD3, 4-HPPD, PPD, HPPDase, Glyoxalase Domain Containing 3, 4-HydroxyphenylpYruvate Dioxygenase.
Source
Escherichia Coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MTTYSDKGAK PERGRFLHFH SVTFWVGNAK QAASFYCSKM GFEPLAYRGL ETGSREVVSH VIKQGKIVFV LSSALNPWNK EMGDHLVKHG DGVKDIAFEV EDCDYIVQKA RERGAKIMRE PWVEQDKFGK VKFAVLQTYG DTTHTLVEKM NYIGQFLPGY EAPAFMDPLL PKLPKCSLEM IDHIVGNQPD QEMVSASEWY LKNLQFHRFW SVDDTQVHTE YSSLRSIVVA NYEESIKMPI NEPAPGKKKS QIQEYVDYNG GAGVQHIALK TEDIITAIRH LRERGLEFLS VPSTYYKQLR EKLKTAKIKV KENIDALEEL KILVDYDEKG YLLQIFTKPV QDRPTLFLEV IQRHNHQGFG AGNFNSLFKA FEEEQNLRGN LTNMETNGVV PGM

Q&A

What is HPD in the context of human biology?

4-Hydroxyphenylpyruvic acid dioxygenase (HPD) is a critical enzyme in tyrosine catabolism in humans. The enzyme is primarily expressed in the liver and is developmentally regulated in mammals. The human HPD gene spans over 30 kb and contains 14 exons, with expression regulated by hepatocyte-specific and liver-enriched transcription factors as well as hormones. Genetic deficiencies in this enzyme lead to hereditary tyrosinemia type 3, an inborn error of metabolism .

When studying HPD in human contexts, researchers should employ the following methodological approaches:

  • Gene expression analysis using liver-specific samples

  • Developmental timing considerations when collecting samples

  • Consideration of transcription factor binding analysis for regulatory studies

  • Enzyme activity assays specific to 4-hydroxyphenylpyruvic acid conversion

What are Human Protection Directives (HPD) in research contexts?

In research contexts, HPD refers to directives and guidelines established to protect human subjects participating in research studies. These directives form a comprehensive framework that ensures ethical conduct in research involving humans. The core principles derive from the Belmont Report, emphasizing respect for persons, beneficence, and justice as fundamental ethical principles .

Methodologically, implementing HPD in research requires:

  • Institutional Review Board (IRB) approval processes

  • Risk assessment protocols specific to research populations

  • Informed consent documentation and procedures

  • Confidentiality and data protection measures

  • Ongoing monitoring of participant welfare throughout the research process

What regulatory frameworks govern human subjects research?

Human subjects research is governed by multiple regulatory frameworks designed to protect participants while enabling valuable scientific inquiry. Key frameworks include:

  • The Common Rule (Part 219 of Title 32, CFR) - Establishes basic provisions for IRBs, informed consent, and compliance monitoring

  • Department of Defense Instruction 3216.02 - Provides specific guidelines for DoD-conducted and supported research

  • FDA regulations - Apply to clinical investigations of drugs, devices, and biologics

  • International guidelines such as the Declaration of Helsinki

Methodologically, navigating these frameworks requires:

  • Determining which regulations apply to specific research contexts

  • Establishing assurance documentation (e.g., Federal-Wide Assurance)

  • Implementing appropriate review processes based on risk levels

  • Creating documentation systems that demonstrate compliance

  • Developing training programs for researchers on applicable regulations

What is tyrosinemia type 3 and how is it related to HPD?

Tyrosinemia type 3 is a rare genetic disorder resulting from deficiency in the enzyme 4-hydroxyphenylpyruvic acid dioxygenase (HPD). This condition disrupts normal tyrosine metabolism, leading to elevated tyrosine levels in the blood and urine. A genetic deficiency in this enzyme in humans and mice leads to this hereditary condition .

The methodological approach to studying this HPD-related condition includes:

  • Genetic testing focusing on the 14 exons of the HPD gene

  • Enzyme activity assays in liver samples or cultured cells

  • Tyrosine and metabolite measurement in biological fluids

  • Animal models of HPD deficiency to study disease mechanisms

  • Developmental tracking of symptom progression and correlation with enzyme activity levels

What are the basic ethical principles guiding human subjects research?

The foundational ethical principles guiding human subjects research derive from the Belmont Report and are incorporated into Human Protection Directives:

  • Respect for Persons: Acknowledging individual autonomy and protecting those with diminished autonomy

  • Beneficence: Maximizing potential benefits while minimizing possible harms

  • Justice: Ensuring fair distribution of research benefits and burdens

Methodologically implementing these principles requires:

  • Developing robust informed consent processes tailored to participant populations

  • Creating appropriate risk-benefit analysis protocols

  • Designing inclusion/exclusion criteria that avoid unnecessary exclusion

  • Establishing mechanisms to protect vulnerable populations

  • Implementing procedures for privacy and confidentiality protection

  • Creating structures for ongoing ethical oversight throughout the research process

How do genetic variations in the human HPD gene affect enzyme function and disease risk?

Genetic variations in the human HPD gene can significantly impact enzyme function and disease risk through multiple mechanisms. Single nucleotide polymorphisms (SNPs), deletions, insertions, and copy number variations within the 14 exons or regulatory regions can alter enzyme expression, stability, or catalytic activity .

Methodologically, researchers investigating these variations should:

  • Employ comprehensive sequencing approaches covering:

    • Coding regions (14 exons)

    • Splice junctions

    • Promoter and enhancer regions

    • 5' and 3' UTRs

  • Utilize functional assays to characterize variant effects:

    • In vitro enzyme activity measurements

    • Cell-based expression systems

    • Protein stability assessments

    • Substrate binding analysis

  • Develop structure-function correlations:

    • Mapping variations to protein structural domains

    • Molecular modeling of variant effects

    • Structure-guided mutagenesis

HPD Genetic Variation TypePotential Functional ImpactResearch Methodology
Missense mutationsAltered catalytic activity, substrate binding, or protein stabilitySite-directed mutagenesis, enzyme kinetics, thermal stability assays
Splicing variantsAltered exon inclusion, truncated proteinsRT-PCR, minigene assays, RNA-seq
Promoter variantsChanged expression levels, developmental regulationLuciferase reporter assays, EMSA, ChIP-seq
Copy number variationsDosage effects, altered expression patternsqPCR, MLPA, genomic microarrays

Researchers should integrate these findings with clinical data to establish genotype-phenotype correlations and potential therapeutic interventions for HPD-related conditions.

What methodological approaches are most effective for studying HPD enzyme kinetics in human liver samples?

Studying HPD enzyme kinetics in human liver samples presents unique challenges due to sample availability, preservation of enzyme activity, and heterogeneity in liver tissue. The most effective methodological approaches combine traditional biochemical techniques with modern analytical methods.

Key methodological considerations include:

  • Sample preparation and preservation:

    • Rapid cryopreservation techniques to maintain enzyme activity

    • Subcellular fractionation to isolate cytosolic components

    • Gentle homogenization methods to preserve protein integrity

    • Buffer optimization to maintain physiological conditions

  • Activity assays:

    • Spectrophotometric monitoring of 4-hydroxyphenylpyruvate consumption

    • HPLC-based quantification of reaction products

    • Oxygen consumption measurements for dioxygenase activity

    • Isotope-labeled substrate tracking

  • Data analysis techniques:

    • Michaelis-Menten kinetics modeling

    • Inhibition studies with competitive and non-competitive inhibitors

    • Temperature and pH dependence analysis

    • Allosteric regulation assessment

ParameterTraditional MethodAdvanced MethodAdvantages of Advanced Method
Km and Vmax determinationLineweaver-Burk plotsNon-linear regression analysisMore accurate with experimental error, no transformation bias
Enzyme quantityWestern blotSelected reaction monitoring (SRM) MSAbsolute quantification, higher specificity
Spatial distributionTissue homogenatesIn situ activity assays, imaging MSPreserved spatial information, cell-type specificity
Reaction productsSpectrophotometryLC-MS/MS metabolomicsHigher sensitivity, multiple product detection

For human liver samples specifically, researchers should consider developmental regulation of HPD as the enzyme activity is expressed mainly in the liver and is developmentally regulated in mammals .

How can researchers balance scientific objectives with human subject protections in challenging research contexts?

Balancing scientific objectives with human subject protections in challenging research contexts requires a nuanced approach that integrates ethical considerations into research design rather than treating them as separate concerns. This is particularly important in contexts involving vulnerable populations, sensitive topics, or high-risk procedures.

Methodological approaches for achieving this balance include:

  • Adaptive study designs:

    • Sequential enrollment strategies that allow early safety assessment

    • Interim analysis plans with predefined stopping rules

    • Adaptive randomization to minimize allocation to less effective arms

    • Enrichment designs that identify responsive subpopulations

  • Risk minimization strategies:

    • Development of surrogate endpoints where possible

    • Minimally invasive sampling techniques

    • Dosage escalation protocols with careful monitoring

    • Enhanced adverse event monitoring systems

  • Enhanced consent processes:

    • Staged consent procedures for complex studies

    • Assessment of comprehension using teach-back methods

    • Involvement of participant advocates or navigators

    • Community engagement in consent development

  • Population-specific considerations:

    • Cultural adaptation of research protocols

    • Assessment of decision-making capacity when needed

    • Specialized protections for vulnerable populations

    • Involvement of community advisory boards

Research ChallengeTraditional ApproachBalanced MethodologyEthical-Scientific Benefit
High-risk interventionExclusion of vulnerable groupsRisk stratification, enhanced monitoringMore inclusive research, generalizable results
Sensitive personal dataMinimal data collectionPrivacy-preserving computation, synthetic dataProtects privacy while enabling complex analysis
Research in emergency settingsWaiver of consentException from informed consent with community consultationEnables critical research while respecting community values
Long-term follow-upLoss to follow-up, incomplete dataParticipant engagement strategies, multiple contact methodsImproved retention, more complete datasets

These approaches align with the DoD policy to follow the Belmont Report principles, including respect for persons, beneficence, and justice .

What are the implications of studying HPD expression in different developmental stages?

Studying HPD expression across different developmental stages has significant implications for understanding both normal physiological processes and disease mechanisms. The developmental regulation of HPD affects tyrosine metabolism, which has downstream effects on multiple biological processes .

Methodological approaches for developmental HPD studies include:

  • Temporal expression profiling:

    • RNA-seq analysis across developmental timepoints

    • Protein quantification in age-matched samples

    • In situ hybridization for spatial-temporal mapping

    • Single-cell RNA-seq for cell-type specific developmental patterns

  • Developmental regulation mechanisms:

    • ChIP-seq for transcription factor binding dynamics

    • Analysis of 5' flanking sequence of the gene for hepatocyte-specific and liver-enriched transcription factors

    • DNA methylation profiling at regulatory regions

    • Histone modification mapping during development

  • Functional implications assessment:

    • Metabolic flux analysis at different developmental stages

    • Phenotypic consequences of stage-specific knockdown

    • Tyrosine and downstream metabolite profiling

    • Tissue-specific effects of altered HPD expression

Developmental StageHPD Expression PatternMetabolic ConsequenceResearch Methodology
FetalLow expression, primarily extrahepaticAlternative tyrosine metabolism pathwaysRNA-seq of fetal tissues, metabolomics
NeonatalRapid increase in hepatic expressionEstablishment of mature tyrosine catabolismLongitudinal liver sampling, promoter analysis
ChildhoodStable high expressionEfficient tyrosine clearancePopulation studies, diet challenge tests
AdultMaintained high expression with individual variationHomeostatic regulationProtein quantification, genetic association studies
AgingPotential decreased activityAltered tyrosine metabolism efficiencyEnzymatic activity assays, proteostasis analysis

Understanding these developmental patterns has implications for timing of dietary interventions in tyrosinemia and developmental windows for gene therapy approaches, especially considering that HPD activity is developmentally regulated in mammals .

How should researchers address conflicts between institutional requirements and broader HPD guidelines?

Researchers frequently encounter situations where institutional requirements may conflict with broader Human Protection Directives or guidelines. Navigating these conflicts requires a systematic approach that maintains compliance while advancing research objectives.

Methodological framework for addressing these conflicts:

  • Conflict identification and analysis:

    • Systematic comparison of institutional versus broader requirements

    • Determination of whether differences are procedural or substantive

    • Assessment of legal versus ethical requirements

    • Identification of jurisdiction and authority hierarchies

  • Harmonization strategies:

    • Development of concordance tables mapping requirements across frameworks

    • Implementation of the more stringent requirement when conflicts exist

    • Creation of supplemental processes to satisfy all applicable requirements

    • Documentation of rationale for selected approaches

  • Collaborative resolution processes:

    • Engagement with institutional officials and IRBs

    • Consultation with external ethics experts

    • Dialogue with regulatory authorities when appropriate

    • Development of consensus interpretations

Conflict AreaResolution ApproachDocumentation RequirementStakeholder Engagement
Informed consent elementsIntegration of all required elements from both frameworksCrosswalk document showing element mappingIRB, legal counsel, study participants
Risk assessment criteriaApplication of most conservative criteria with explanationRisk analysis showing multiple framework considerationsSafety monitoring board, IRB
Privacy protection standardsImplementation of technical solutions meeting all standardsData protection impact assessmentPrivacy officers, IT security, participants
Reporting requirementsDevelopment of comprehensive reporting scheduleReporting matrix with timelines and recipientsRegulatory affairs, sponsors, IRB

When addressing conflicts, researchers should remember that DoD institutions and all non-DoD institutions conducting human subjects research that receive support from the DoD must comply with the terms of their federal assurances, if they hold one, the DoD instructions, and relevant policies of the cognizant DoD Component .

What statistical considerations are essential when designing human subjects research with vulnerable populations?

Designing human subjects research involving vulnerable populations requires specialized statistical approaches that balance scientific rigor with ethical protections. These considerations go beyond standard statistical methods to address unique challenges related to sample sizes, heterogeneity, and ethical constraints.

Essential statistical considerations include:

  • Sample size and power calculations:

    • Accounting for potentially higher attrition rates

    • Adjusting for heterogeneity within vulnerable groups

    • Considering ethical limitations on sample size

    • Implementing adaptive designs to minimize participant burden

  • Selection and allocation methods:

    • Stratified randomization to ensure appropriate representation

    • Minimization techniques to balance key covariates

    • Cluster randomization when appropriate for community-based approaches

    • Sequential allocation methods to minimize risk exposure

  • Analytical approaches:

    • Mixed effects models to account for clustered data

    • Sensitivity analyses for missing data patterns

    • Bayesian methods to incorporate prior information

    • Propensity score methods to address selection bias

Statistical ChallengeTraditional ApproachVulnerable Population ApproachMethodological Advantage
Sample size limitationsFixed sample size designSequential or adaptive designMinimizes number of participants exposed to risks
HeterogeneityBroad inclusion criteriaStratified analysis, precision recruitmentAccounts for important subgroup effects
Missing dataComplete case analysisPattern mixture models, multiple imputationReduces bias from differential attrition
Outcome measurementStandardized instrumentsCulturally adapted, validated measuresImproves validity for specific populations

These considerations align with DoD requirements to provide additional safeguards for subjects who are likely to be vulnerable to coercion or undue influence .

How can researchers effectively implement HPD requirements in multinational collaborative studies?

Implementing Human Protection Directives in multinational collaborative studies presents complex challenges due to varying regulatory frameworks, ethical standards, and cultural contexts. Effective implementation requires comprehensive planning and ongoing coordination.

Methodological framework for multinational HPD implementation:

  • Regulatory mapping and harmonization:

    • Comprehensive analysis of applicable regulations across all study sites

    • Identification of common requirements and country-specific elements

    • Development of integrated protocols that satisfy all jurisdictions

    • Creation of harmonized documentation templates with modular components

  • Ethics review coordination:

    • Implementation of parallel submission processes

    • Establishment of communication channels between ethics committees

    • Development of response protocols for site-specific concerns

    • Creation of amendment tracking systems across jurisdictions

  • Consent process adaptations:

    • Cultural and linguistic validation of consent materials

    • Local customization while maintaining core elements

    • Documentation standards appropriate to each setting

    • Procedures for consent monitoring across sites

Implementation AreaGlobal Standard ApproachLocal Adaptation RequirementsCoordination Mechanism
Ethics reviewPrimary IRB of record with reliance agreementsLocal committee review for cultural appropriatenessCoordinated submission timeline, response template
Informed consentCore elements standardized across sitesLanguage, format, and process adapted locallyCertified translations, cultural equivalence assessment
Adverse event reportingStandardized definitions and formsCountry-specific reporting timelines and authoritiesCentralized tracking system with automated alerts
Data privacy protectionMinimum universal standardsAdditional protections for stricter jurisdictionsTiered protection system meeting highest standards

These approaches are particularly relevant when considering that all researchers conducting non-exempt human subjects research must be covered by their own institution's federal assurance or by another institution's federal assurance through an Individual Investigator Agreement .

What are best practices for documenting informed consent in HPD-compliant research?

Documenting informed consent in HPD-compliant research goes beyond simply obtaining signatures on forms. Best practices encompass the entire consent process from development through implementation to storage and access control.

Methodological approach to consent documentation:

  • Consent form development and validation:

    • Reading level assessment using validated tools

    • Usability testing with representative participant populations

    • Translation and back-translation for non-English forms

    • Version control systems for tracking changes

  • Process documentation methods:

    • Standardized checklists for consent conversations

    • Audio recording of consent discussions when appropriate

    • Documentation of participant questions and responses

    • Time-stamped electronic signatures with audit trails

  • Special circumstances accommodation:

    • Protocols for documenting consent from participants with limited literacy

    • Documentation standards for legally authorized representatives

    • Methods for ongoing consent verification in longitudinal studies

    • Emergency research consent exception documentation

Consent Documentation ElementTraditional ApproachEnhanced MethodologyCompliance Advantage
Comprehension assessmentVerbal confirmationTeach-back documentation, comprehension quizzesDemonstrates understanding, not just process completion
Signature collectionPaper forms with signaturesElectronic consent with biometric verification, audit trailsTamper-evident, timestamped documentation
Process verificationResearch coordinator attestationNeutral witness documentation, video recordingIndependent verification of proper procedures
Remote consentMailed formsVideoconference with recording, electronic signature platformsMaintains interactive nature while expanding accessibility

These practices align with DoD policy requiring that informed consent be obtained in accordance with the Common Rule and documented in a signed written document that embodies the elements of informed consent .

How should institutions implement training programs for HPD compliance?

Implementing effective training programs for Human Protection Directives compliance requires a systematic approach that addresses both regulatory requirements and practical application. These programs must balance comprehensive coverage with accessibility and engagement.

Methodological framework for HPD training implementation:

  • Needs assessment and curriculum development:

    • Regulatory analysis to identify required training elements

    • Role-based competency mapping for targeted content

    • Knowledge gap assessment through pre-testing

    • Modular design allowing customization for different roles

  • Delivery methods optimization:

    • Blended learning approaches combining online and in-person elements

    • Case-based learning for practical application

    • Just-in-time training components for specific research activities

    • Micro-learning modules for reinforcement and updates

  • Assessment and documentation:

    • Multi-modal assessment strategies beyond knowledge testing

    • Performance-based evaluation of key skills

    • Documentation systems meeting regulatory requirements

    • Certificate generation and tracking mechanisms

Training ComponentBasic ResearchersClinical ResearchersIRB MembersResearch Leadership
Ethical principlesFoundational conceptsApplication in clinical contextsEvaluative frameworksInstitutional responsibility
Regulatory requirementsGeneral overviewStudy-specific applicationsDetailed regulatory reviewCompliance oversight systems
Informed consentBasic elementsProcess implementation, difficult situationsEvaluation criteriaPolicy development
Vulnerable populationsIdentification, general protectionsSpecialized approaches, capacity assessmentAdditional safeguard evaluationInstitutional safeguards

This approach aligns with DoD requirements for establishing guidance for DoD Component human subject protection training and courses like HPD 601: Human Subjects: Ethics and Responsible Conduct of Research, which incorporate components focused on identifying ethical principles associated with human subjects research .

What resources are available for researchers studying HPD-related disorders?

Researchers studying HPD-related disorders such as tyrosinemia type 3 have access to various resources to support their investigations. A methodological approach to utilizing these resources includes:

  • Genomic and molecular resources:

    • Human HPD gene sequence and structural information

    • Genetic variation databases specific to HPD mutations

    • Tissue banks for accessing liver samples with HPD expression

    • Cell lines and animal models with HPD mutations

  • Clinical and translational resources:

    • Patient registries for tyrosinemia and related disorders

    • Biospecimen repositories with annotated clinical data

    • Natural history studies documenting disease progression

    • Clinical trial networks for rare metabolic disorders

  • Educational and training resources:

    • Specialized courses on human subjects research ethics

    • Graduate-level training in population health research methods

    • Workshops on advanced research methodologies

    • Mentored research opportunities in population health

Resource TypeApplication in Basic ResearchApplication in Clinical ResearchAccess Mechanism
Genetic databasesIdentifying variants for functional studiesCorrelating genotypes with clinical phenotypesPublic databases (ClinVar, gnomAD)
Biospecimen repositoriesIn vitro enzymatic studies, expression analysisBiomarker identification, metabolomicsInstitutional biobanks, patient advocacy organizations
Training programsExperimental design, statistical analysisClinical trial methodology, outcomes measurementUniversity courses, workshops, online modules
Regulatory guidanceEthical considerations for gene editingProtocol development for vulnerable populationsFederal websites, institutional IRB offices

These resources support both the scientific understanding of HPD biology and the ethical conduct of human research, as outlined in courses like HPD 681: Advanced Social Determinants of Health and the DoD guidelines for human subjects protection .

How are HPD research methodologies evolving to address emerging challenges?

Research methodologies in both HPD enzyme studies and human protection directives are evolving rapidly to address emerging challenges. This evolution reflects technological advances, changing ethical standards, and increasing complexity in research designs.

In HPD enzyme research, methodological evolution includes:

  • Integration of multi-omics approaches to understand gene-environment interactions affecting HPD function

  • Development of patient-derived organoids to study liver-specific HPD expression patterns

  • Application of CRISPR-based gene editing to create precise HPD variants for functional studies

  • Implementation of advanced computational modeling to predict the effects of novel HPD mutations

In human protection directives, methodological advances include:

  • Development of flexible review pathways proportionate to research risks

  • Creation of participant-centered approaches to informed consent and research engagement

  • Implementation of privacy-preserving computational methods for sensitive data analysis

  • Establishment of community engagement frameworks for research with marginalized populations

Both areas benefit from interdisciplinary approaches that combine biomedical sciences, ethics, statistics, and regulatory expertise to address complex research questions while maintaining appropriate protections for research participants .

The future of HPD research will likely continue to emphasize integration of basic science discoveries with ethically sound clinical applications, as reflected in programs like those at Stony Brook University that combine methodological training with ethical research conduct education .

Product Science Overview

Introduction

4-Hydroxyphenylpyruvate dioxygenase (HPPD) is an essential enzyme in the catabolic pathway of the amino acid tyrosine. It catalyzes the conversion of 4-hydroxyphenylpyruvate to homogentisate, a crucial step in the breakdown of tyrosine. This enzyme is found in nearly all aerobic organisms and plays a significant role in various metabolic processes.

Structure and Function

HPPD is an Fe(II)-containing non-heme oxygenase. The enzyme typically forms homodimers in eukaryotes, with each subunit having a mass of approximately 40-50 kDa . The active site of HPPD is composed of residues near the C-terminus of the enzyme, and it contains an iron ion essential for its catalytic activity .

The reaction catalyzed by HPPD involves the oxidative decarboxylation of 4-hydroxyphenylpyruvate, leading to the formation of homogentisate. This process includes an NIH shift, where an alkyl group migrates to form a more stable carbocation . The enzyme’s mechanism is unique because it does not use α-ketoglutarate as a cofactor, unlike other oxygenases in its class .

Biological Significance

HPPD is involved in the catabolism of tyrosine, an aromatic amino acid. This pathway is crucial for the proper metabolism of tyrosine, and defects in the HPPD gene can lead to metabolic disorders such as tyrosinemia type 3 and hawkinsinuria . These conditions result from the accumulation of toxic intermediates due to the impaired breakdown of tyrosine.

Recombinant HPPD

Recombinant HPPD refers to the enzyme produced through recombinant DNA technology, where the HPPD gene is cloned and expressed in a host organism, such as Escherichia coli. This approach allows for the large-scale production of the enzyme for research and therapeutic purposes. Recombinant HPPD retains the same structural and functional properties as the native enzyme, making it a valuable tool for studying its biochemical characteristics and potential applications.

Applications and Research

Research on HPPD has significant implications for both basic science and clinical applications. Understanding the enzyme’s structure and function can provide insights into its role in metabolic pathways and its potential as a target for therapeutic interventions. For instance, inhibitors of HPPD are used as herbicides, and there is ongoing research into their potential use in treating metabolic disorders related to tyrosine catabolism .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.